• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[关于在生物材料中用硝基苄基吡啶(NBP)测定氮芥烷基化活性的方法(作者译)]

[On the methodology of the determination of alkylating activities of nitrogen mustards with nitrobenzylpyridine (NBP) in biological material (author's transl)].

作者信息

Hesse G, Schulze W, Wachtel E

出版信息

Pharmazie. 1981 Sep;36(9):609-12.

PMID:7301901
Abstract

It is dealt with modifications to the spectrophotometric determination of the alkylating behaviour of bifunctional nitrogen mustards with 4-(4'-nitrobenzyl)pyridine (NBP). The authors succeeded in characterizing spectrophotometrically, by means of a one-phase procedure, not only soluble, but also difficultly soluble, therapeutically known and newly synthetized mustards in regard to their alkylating behaviour. In the framework of in vitro studies, the authors report of experimental details of the proper preparation of biological material for the determination of residual activities, the analytical approach being always depending on the structure of the respective mustard. The differences in the time courses of the acylating attacks in serum, blood and suspensions of leukaemic cells are demonstrated by the example of some selected nitrogen mustards.

摘要

本文论述了对用4-(4'-硝基苄基)吡啶(NBP)分光光度法测定双功能氮芥烷基化行为的改进。作者成功地通过单相程序用分光光度法表征了不仅可溶的,而且难溶的、治疗上已知的和新合成的氮芥的烷基化行为。在体外研究的框架内,作者报告了用于测定残留活性的生物材料的适当制备的实验细节,分析方法总是取决于各自氮芥的结构。通过一些选定的氮芥的例子展示了血清、血液和白血病细胞悬液中酰化攻击时间进程的差异。

相似文献

1
[On the methodology of the determination of alkylating activities of nitrogen mustards with nitrobenzylpyridine (NBP) in biological material (author's transl)].[关于在生物材料中用硝基苄基吡啶(NBP)测定氮芥烷基化活性的方法(作者译)]
Pharmazie. 1981 Sep;36(9):609-12.
2
[Methodology of the colorimetric determination of alkylating cytostatics with 4-(4'-nitrobenzyl)pyridine (NBP) in plasma].
Pharmazie. 1982 Nov;37(11):777-9.
3
Different inhibitory effect of nitrogen mustard (HN2) and TS-160 (HN3) on choline transport in L 5178Y lymphoblasts.氮芥(HN2)和TS - 160(HN3)对L 5178Y淋巴母细胞中胆碱转运的不同抑制作用。
Neoplasma. 1975;22(6):621-3.
4
Potential anticancer agents. XVII. New developments in the benzoic acid nitrogen mustards area.
Cancer Treat Rep. 1978 Dec;62(12):2045-54.
5
Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.氮芥作为烷化抗癌药物的治疗历程:从历史到未来展望。
Eur J Med Chem. 2018 May 10;151:401-433. doi: 10.1016/j.ejmech.2018.04.001. Epub 2018 Apr 3.
6
Comparison of the action of ionizing radiations and biological alkylating agents (nitrogen mustards) at the cellular and sub-cellular level.
Sci Rep Ist Super Sanita. 1961 Oct;1:537-50.
7
Enzyme-alterable alkylating agents. IX. The enzymatic transformation of some nitrogen mustards in the presence of carbon dioxide: implications in respiration.酶可变烷基化剂。IX. 二氧化碳存在下某些氮芥的酶促转化:对呼吸的影响。
Cancer Res. 1966 Feb;26(2):323-30.
8
Synthesis and biological evaluation of cyclic nitrogen mustards based on carnitine framework.基于肉碱骨架的环氮芥的合成与生物评价。
Eur J Med Chem. 2010 Sep;45(9):4140-8. doi: 10.1016/j.ejmech.2010.06.003. Epub 2010 Jun 9.
9
DNA-directed alkylating agents. 1. Structure-activity relationships for acridine-linked aniline mustards: consequences of varying the reactivity of the mustard.DNA 导向的烷化剂。1. 吖啶连接的苯胺氮芥的构效关系:改变氮芥反应性的影响
J Med Chem. 1990 Apr;33(4):1177-86. doi: 10.1021/jm00166a015.
10
Structure-activity relationship of a series of nitrogen mustard- and pyrrole-containing minor groove-binding agents related to distamycin.一系列与偏端霉素相关的含氮芥和吡咯的小沟结合剂的构效关系
Anticancer Drug Des. 1994 Dec;9(6):511-25.

引用本文的文献

1
Bendamustine in B-Cell Malignancies: The New 46-Year-Old Kid on the Block.苯达莫司汀治疗B细胞恶性肿瘤:该领域的新“46岁新秀”
Clin Cancer Res. 2009 Dec 15;15(24):7456-7461. doi: 10.1158/1078-0432.CCR-08-3041.
2
Bendamustine HCL for the treatment of relapsed indolent non-Hodgkin's lymphoma.盐酸苯达莫司汀治疗复发性惰性非霍奇金淋巴瘤。
Ther Clin Risk Manag. 2008 Aug;4(4):727-32. doi: 10.2147/tcrm.s3158.